Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 9/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.46 |
| ▸ | CASP2 | P42575 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 6/20 | 0.41 |
| ▸ | PPARD | Q03181 | 6/20 | 0.41 |
| ▸ | PPARA | Q07869 | 6/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30812349 | 1.00 | EPHX1 (0.48) | EPHX1KDM4CCASP2PPARGPPARD | |
| SCHEMBL30255194 | 1.00 | EPHX1 (0.48) | EPHX1KDM4CCASP2PPARGPPARD | |
| SCHEMBL29437846 | 1.00 | EPHX1 (0.48) | EPHX1KDM4CCASP2PPARGPPARD | |
| SCHEMBL3856282 | 1.00 | EPHX1 (0.48) | EPHX1KDM4CCASP2PPARGPPARD | |
| SCHEMBL3850619 | 1.00 | EPHX1 (0.48) | EPHX1KDM4CCASP2PPARGPPARD | |
| Hydrochloric Acid SCHEMBL11673567 | 0.98 | EPHX1 (0.47) | EPHX1KDM4CCASP2PPARGPPARD | |
| SCHEMBL3885213 | 0.98 | KDM4C (0.47) | EPHX1KDM4CCASP2PPARGPPARD | |
| SCHEMBL28370224 | 0.91 | KDM4C (0.48) | EPHX1KDM4CALOX15 | |
| Glycinebetaine SCHEMBL4800074 | 0.84 | CPT2 (0.40) | EPHX1KDM4C | |
| Glycinebetaine SCHEMBL4799206 | 0.84 | CPT2 (0.40) | EPHX1KDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118028922-A | Additive for composite plating solution | 株式会社杰希优 | 2024-05-14 | — | — | CN | disclosed |
| EP-3315578-B1 | WATER REPELLENT COMPOSITION, METHOD FOR PRODUCING WATER REPELLENT COMPOSITION, AND ARTICLE | AGC INC (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-20240016245-A1 | ANTIMICROBIAL FACEMASK | BMG (BRITISH MEDICAL GROUP) LIMITED (GB) | 2024-01-18 | — | — | US | disclosed |
| EP-4225035-A1 | ANTIMICROBIAL FACEMASK | BMG (British Medical Group) Limited (GB) | 2023-08-16 | — | — | EP | disclosed |
| CN-115478307-A | Additive for composite plating solution | 株式会社杰希优 | 2022-12-16 | — | — | CN | disclosed |
| WO-2022074384-A1 | ANTIMICROBIAL FACEMASK | CHEMICAL INTELLIGENCE LIMITED (GB) | 2022-04-14 | — | — | WO | disclosed |
| EP-3981252-A1 | ANTIMICROBIAL FACEMASK | Chemical Intelligence Limited (GB) | 2022-04-13 | — | — | EP | disclosed |
| CN-108348430-B | Cleaning agent composition for pump bubbler | 株式会社资生堂 | 2022-02-15 | — | — | CN | disclosed |
| US-20140017301-A1 | DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN | CEVC GREGOR (DE) | 2014-01-16 | — | — | US | disclosed |
| WO-2012126965-A1 | DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN | CEVC GREGOR (DE) | 2012-09-27 | — | — | WO | disclosed |
| EP-1133447-B1 | WATER-SOLUBLE NANOSTRUCTURED METAL-OXIDE COLLOIDS AND METHOD FOR PREPARING THE SAME | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2004-04-21 | — | — | EP | disclosed |
| EP-1133447-A1 | WATER-SOLUBLE NANOSTRUCTURED METAL-OXIDE COLLOIDS AND METHOD FOR PREPARING THE SAME | Studiengesellschaft Kohle mbH (DE) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000029332-A1 | WATER-SOLUBLE NANOSTRUCTURED METAL-OXIDE COLLOIDS AND METHOD FOR PREPARING THE SAME | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2000-05-25 | — | — | WO | disclosed |
| US-5391300-A | Sorbing polychlorinated biphenyls with polymeric material; desorbing | GENERAL ELECTRIC COMPANY (US) | 1995-02-21 | — | — | US | disclosed |
| US-4272396-A | DISHES AND LAUNDRY DETERGENT | THE LION FAT & OIL CO., LTD. (JP) | 1981-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016245-A1 | ANTIMICROBIAL FACEMASK | AMPD3, AMPD1, AMPD2 | EPHX1 4167/4885KDM4C 4603/4885CASP2 1762/4885 |
| US-20140017301-A1 | DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN | EXOSC9, EXOSC5, TNNC1 | EPHX1 2978/4885KDM4C 4385/4885CASP2 1394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.